The impact of Hubbard and van der Waals corrections on the DFT calculation of epsilon-zeta transition pressure in solid oxygen.

Phys Chem Chem Phys

Institute for Solid State Physics, The University of Tokyo, Kashiwa-no-ha, Kashiwa, Chiba, 277-8581, Japan.

Published: September 2023

In this study, we aim to clarify the physics that governs the unique properties of the transition between epsilon and zeta phases in solid oxygen observed at 96 GPa by using density functional theory (DFT) calculations. We first conduct the calculation using various functionals, namely, LDA, PBE, BLYP, and TPSS. The results show that LDA and TPSS predict the epsilon-zeta transition pressure at 30 GPa, while PBE and BLYP show the transition at 40 GPa. Then we include the van der Waals correction (either vdW functionals or semi-empirical methods) to improve the nonlocal effects in epsilon oxygen. The transition pressure is improved to 50 GPa. Finally, the Hubbard correction is added to enhance the localization and short-range interactions. The final epsilon-zeta transition pressure is significantly improved to 80 GPa. This demonstrates that the contribution from the local interaction is higher than the nonlocal London dispersion term at the metallization point. Moreover, this approach suggests that the van der Waals correction may correctly capture the nonlocal interaction in solid oxygen. The nonlocal effect is expected to be dominant below 20 GPa. A correct treatment of the local and nonlocal interactions on an equal footing is important to study solid oxygen.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d3cp02566gDOI Listing

Publication Analysis

Top Keywords

transition pressure
16
solid oxygen
16
van der
12
der waals
12
epsilon-zeta transition
12
pbe blyp
8
waals correction
8
pressure improved
8
improved gpa
8
transition
6

Similar Publications

Pulmonary arterial hypertension (PAH) is a rare and potentially fatal condition characterized by progressive increases in blood pressure in the arteries of the lungs. Oral selexipag, approved by the Food and Drug Administration (FDA) in 2015 for the treatment of PAH, targets prostacyclin receptors on pulmonary arterial vascular smooth muscle and endothelial cells to improve blood flow through the lungs and reduce pulmonary vascular resistance. Oral selexipag is effective, but may be discontinued due to factors like side effects, emergency conditions, or inability to take oral medication, potentially leading to severe adverse events, such as rebound pulmonary hypertension and right heart failure.

View Article and Find Full Text PDF

We present a new, to the best of our knowledge, approach for self-heterodyne optical frequency comb (OFC) spectroscopy in which a single Mach-Zehnder modulator is utilized to generate both an optical frequency comb and a frequency-shifted local oscillator. This method allows for coherent, time-domain averaging to be performed without the need for feedback mechanisms or software corrections. As an initial demonstration, we have measured acetylene rovibrational transition frequencies with coherently averaged comb spectra.

View Article and Find Full Text PDF

Blood-brain barrier (BBB) dysfunction is suggested to be a potential mediator between vascular risk factors and cognitive impairment, leading to vascular cognitive impairment. To investigate the relationships between age, sex, and vascular risk factors and BBB water permeability as well as their relationship with cognition. To measure BBB permeability, a novel arterial spin labelling MRI technique (ME-ASL) was applied to derive the time of exchange (Tex), arterial time transit (ATT), and cerebral blood flow (CBF).

View Article and Find Full Text PDF

Guidance for Prescribing Oral Antihypertensive Medications in the Emergency Department.

Curr Hypertens Rep

January 2025

Department of Emergency Medicine, Integrative Biosciences Center, Wayne State University, Detroit, MI, USA.

Purpose Of Review: To review the most current recommendations regarding assessment and treatment of asymptomatic hypertension treatment in the emergency department (ED) and to provide guidance for prescribing oral antihypertensive therapy for ED providers.

Recent Findings: There are varying management strategies for the treatment of asymptomatic hypertension in the ED likely due to a lack of direct guidelines for treatment. There is an increasing body of evidence for the safety of initiating therapy to treat chronic asymptomatic hypertension in the ED.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!